lost < low < lower

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 64.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000010 (2011)	Katsuaki Kanbe [Japon] ; Atsushi Nakamura [Japon] ; Yasuo Inoue [Japon] ; Kaori Hobo [Japon]	Osteoprotegerin expression in bone marrow by treatment with tocilizumab in rheumatoid arthritis
000014 (2012)	Seiji Ohtori [Japon] ; Masayuki Miyagi [Japon] ; Yawara Eguchi [Japon] ; Gen Inoue [Japon] ; Sumihisa Orita [Japon] ; Nobuyasu Ochiai [Japon] ; Shunji Kishida [Japon] ; Kazuki Kuniyoshi [Japon] ; Junichi Nakamura [Japon] ; Yasuchika Aoki [Japon] ; Tetsuhiro Ishikawa [Japon] ; Gen Arai [Japon] ; Hiroto Kamoda [Japon] ; Miyako Suzuki [Japon] ; Masashi Takaso [Japon] ; Takeo Furuya [Japon] ; Gou Kubota [Japon] ; Yoshihiro Sakuma [Japon] ; Yasuhiro Oikawa [Japon] ; Tomoaki Toyone [Japon] ; Kazuhisa Takahashi [Japon]	Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica
000027 (2010)	Taio Naniwa [Japon] ; Rei Ito [Japon] ; Maiko Watanabe [Japon] ; Yoshihito Hayami [Japon] ; Shinji Maeda [Japon] ; Kaneshige Sasaki [Japon] ; Shiho Iwagaitsu [Japon]	Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still’s disease
000043 (2009)	Kazuko Matsumoto [Japon] ; Takao Nagashima [Japon] ; Shino Takatori [Japon] ; Yuta Kawahara [Japon] ; Masaki Yagi [Japon] ; Masahiro Iwamoto [Japon] ; Hitoaki Okazaki [Japon] ; Seiji Minota [Japon]	Glucocorticoid and cyclosporine refractory adult onset Still’s disease successfully treated with tocilizumab
000050 (2011)	Masaaki Hiura [Japon] ; Shintaro Abe ; Akinari Tabaru ; Shohei Shimajiri ; Kentaro Hanami [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Masaru Harada	Case of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis
000076 (2011)	Makoto Hirao [Japon] ; Naomi Yamasaki [Japon] ; Hiroki Oze [Japon] ; Kosuke Ebina [Japon] ; Akihide Nampei [Japon] ; Yoshitaka Kawato [Japon] ; Kenrin Shi [Japon] ; Hideki Yoshikawa [Japon] ; Norihiro Nishimoto [Japon] ; Jun Hashimoto [Japon]	Serum level of oxidative stress marker is dramatically low in patients with rheumatoid arthritis treated with tocilizumab
000113 (2005)	Josef S. Smolen [Autriche] ; Kurt Redlich [Autriche] ; Jochen Zwerina [Autriche] ; Daniel Aletaha [Autriche] ; Günter Steiner [Autriche] ; Georg Schett [Autriche]	Pro-inflammatory cytokines in rheumatoid arthritis
000125 (2012)	Nicolas Rohleder [États-Unis] ; Martin Aringer [Allemagne] ; Matthias Boentert [Allemagne]	Role of interleukin‐6 in stress, sleep, and fatigue
000133 (2009)	Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami [Japon] ; Satoshi Yamasaki [Japon] ; Takahiro Imazato [Japon] ; Naoki Iwamoto [Japon] ; Keita Fujikawa [Japon] ; Toshiyuki Aramaki [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Hiroaki Ida [Japon] ; Tomoki Origuchi [Japon] ; Yukitaka Ueki [Japon] ; Katsumi Eguchi [Japon]	Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis
000135 (2012)	K. Krüger [Allemagne] ; J. Wollenhaupt [Allemagne] ; K. Albrecht [Allemagne] ; R. Alten [Allemagne] ; M. Backhaus [Allemagne] ; C. Baerwald [Allemagne] ; W. Bolten [Allemagne] ; J. Braun [Allemagne] ; H. Burkhardt [Allemagne] ; G. Burmester [Allemagne] ; M. Gaubitz [Allemagne] ; A. Gause [Allemagne] ; E. Gromnica-Ihle [Allemagne] ; H. Kellner [Allemagne] ; J. Kuipers [Allemagne] ; A. Krause [Allemagne] ; H.-M. Lorenz [Allemagne] ; B. Manger [Allemagne] ; H. Nü Lein [Allemagne] ; H.-G. Pott [Allemagne] ; A. Rubbert-Roth [Allemagne] ; M. Schneider [Allemagne] ; C. Specker [Allemagne] ; H. Schulze-Koops [Allemagne] ; H.-P. Tony [Allemagne] ; S. Wassenberg [Allemagne] ; U. Müller-Ladner [Allemagne]	S1-Leitlinie der DGRh zur sequenziellen medikamentösen Therapie der rheumatoiden Arthritis 2012
000139 (2016)	Khalid M. Malik [États-Unis] ; Ariana Nelson [États-Unis] ; Honorio Benzon [États-Unis]	Disease‐modifying Antirheumatic Drugs for the Treatment of Low Back Pain: A Systematic Review of the Literature
000154 (2011)	Atsushi Kaneko [Japon] ; Daihei Kida [Japon] ; Kiwamu Saito [Japon] ; Masami Tsukamoto [Japon] ; Tomotaro Sato [Japon]	Clinical results for tocilizumab over one year in the clinical setting as assessed by CDAI (clinical disease activity index): CRP at week 12 and MMP-3 at week 24 are predictive factors for CDAI
000178 (2010)	G. Dückers [Allemagne] ; T. Niehues [Allemagne]	Die Bedeutung von Biologika bei der Therapie der SoJIA (Morbus Still)
000204 (2010)	C. J. Edwards [Royaume-Uni] ; E. Williams [Royaume-Uni]	The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis
000246 (2011)	Bernard Bannwarth [France]	Prise en charge thérapeutique de l’inflammation d’origine rhumatismale
000303 (2013)	Verena Wieser [Autriche] ; Alexander R. Moschen [Autriche] ; Herbert Tilg [Autriche]	Inflammation, Cytokines and Insulin Resistance: A Clinical Perspective
000305 (2012)	J. Wollenhaupt [Allemagne] ; K. Krüger [Allemagne]	Frühe und fortgeschrittene rheumatoide Arthritis
000308 (2013)	M. Vis [Pays-Bas] ; M. Güler-Yüksel [Pays-Bas] ; W. F. Lems [Pays-Bas]	Can bone loss in rheumatoid arthritis be prevented?
000326 (2015)	Takeshi Sainoh [Japon] ; Sumihisa Orita [Japon] ; Masayuki Miyagi [Japon] ; Yoshihiro Sakuma [Japon] ; Kazuyo Yamauchi [Japon] ; Miyako Suzuki [Japon] ; Go Kubota [Japon] ; Yasuhiro Oikawa [Japon] ; Kazuhide Inage [Japon] ; Jun Sato [Japon] ; Kazuki Fujimoto [Japon] ; Yasuhiro Shiga [Japon] ; Gen Inoue [Japon] ; Yasuchika Aoki [Japon] ; Kazuhisa Takahashi [Japon] ; Seiji Ohtori [Japon]	Interleukin‐6 and interleukin‐6 receptor expression, localization, and involvement in pain‐sensing neuron activation in a mouse intervertebral disc injury model
000393 (2011)	Masahiro Iwamoto [Japon] ; Sumiko Homma [Japon] ; Sachiko Onishi [Japon] ; Yasuyuki Kamata [Japon] ; Katsuya Nagatani [Japon] ; Zentaro Yamagata [Japon] ; Seiji Minota [Japon]	Low level of seroconversion after a novel influenza A/H1N1/2009 vaccination in Japanese patients with rheumatoid arthritis in the 2009 season
000408 (2013)	N. Van Herwaarden ; S. Herfkens-Hol ; A. Van Der Maas ; B. Van Den Bemt [Pays-Bas] ; R. Van Vollenhoven [Suède] ; J. Bijlsma [Pays-Bas] ; A. Den Broeder	AB0324 Dose reduction of tocilizumab in rheumatoid arthritis patients with low disease activity: a pilot study

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "low" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "low" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    low
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021